CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Tianyin Pharmaceutical Co., Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Tianyin Pharmaceutical Co., Inc.
23rd Floor, Unionsun Yangkuo Plaza,
No. 2, 3rd block, South Renmin Road
Phone: +86 2885516696p:+86 2885516696 Chengdu, SIC  610041  China Fax: +86 2885516676f:+86 2885516676
This company is no longer actively traded on any major stock exchange.
Business Summary
Tianyin Pharmaceutical Co., Inc. is a pharmaceutical company. Through the Company’s indirect wholly owned subsidiary, Chengdu Tianyin Pharmaceutical Co., Ltd., it is engaged in the development, manufacturing, marketing and sales of patented biopharmaceutical medicines, branded generics, modernized traditional Chinese medicines and other pharmaceuticals in China. As of June 30, 2013, the Company is manufacturing a range of 58 products approved by the China Food and Drug Administration (CFDA), 24 of which are listed in the National Medical Reimbursement List (NMRL) and 10 are listed in the Essential Drug List (EDL) of the China. The Company’s medicines are used in the therapeutic areas of internal medicines, gynecology, hepatology, otolaryngology, urology, neurology, dermatology, pediatrics, gastroenterology and orthopedics. The Company markets its products through regional distributors, as well as directly to the hospitals, clinics and pharmacies.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
3/31/20156/30/2014YesYes---

Industries
SIC Code Description
2834 Pharmaceutical preparations
7389 Business services, not elsewhere classified
8731 Commercial physical and biological research
6719 Offices of holding companies, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer, Acting Chief Financial Officer GuoqingJiang 48 1/5/2015
Chief Operating Officer TaoYang 46 1/1/2011 9/28/2009
Chief Technology Officer XintaoYou
4 additional Officers and Directors records available in full report.

Business Names
Business Name
Chengdu Tianyin Pharmaceutical Co., Ltd.
Qionglai Tianyin Pharmaceutical Co., Ltd.
Tianyin Pharmaceutical Co, Inc.
7 additional Business Names available in full report.

General Information
Number of Employees: 1,000 (As of 6/30/2014)
Outstanding Shares: 29,432,791 (As of 8/11/2015)
Shareholders: 261
Stock Exchange: OTC
Federal Tax Id: 204857782
Fax Number: +86 2885516676


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023